RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
57 hedge funds and large institutions have $1.11B invested in Rubius Therapeutics, Inc in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $1.54B → $1.11B (-$430M)
Holders
57
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$13.5M | |
| 2 | +$10.6M | |
| 3 | +$3.43M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$2.67M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$2.36M |
Top Sellers
| 1 | -$2.49M | |
| 2 | -$1.66M | |
| 3 | -$1.41M | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.32M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.2M |